Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (571-580 of 609) with videos related to

Pageof 61
Sort By:
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsisLaurent Billot, Jeffrey Lipman, Stephen J Brett, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU studyJason A Roberts, Fekade Sime, Jeffrey Lipman, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2015
Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC projectMercedes Delgado-Valverde, Eva Torres, Adoración Valiente-Mendez, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Corrigendum to "Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis" [Crit Care Resusc 23(3) (2021) 273-284]Laurent Billot, Jeffrey Lipman, Stephen J Brett, et al.
Intensive Care Medicine|February 3, 2025
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units-the SAFE-ICU studyJason A Roberts, Fekade B Sime, Jeffrey Lipman, et al.
The Journal of Antimicrobial Chemotherapy|January 21, 2014
An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care unitsGloria Wong, Alexander Brinkman, Russell J Benefield, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Protocol for an international, multicentre, prospective, observational study of nosocomial pneumonia in intensive care units: the PneumoINSPIRE studyDespoina Koulenti, Apostolos Armaganidis, Kostoula Arvaniti, et al.
Intensive Care Medicine|June 11, 2020
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA studyLiesbet De Bus, Pieter Depuydt, Johan Steen, et al.
Wellcome Open Research|February 16, 2026
An oropharyngeal gonorrhoea controlled human infection model: a provisional protocol using a novel <i>Neisseria gonorrhoeae</i> challenge strainEloise Williams, Georgina L Pollock, David J Price, et al.
Clinical Pharmacokinetics|December 25, 2024
A Pooled Pharmacokinetic Analysis for Piperacillin/Tazobactam Across Different Patient Populations: From Premature Infants to the ElderlyDaming Kong, Jason A Roberts, Jeffrey Lipman, et al.
Pageof 61

Showing results (571-580 of 609) with videos related to

Sort By:
Pageof 61
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsisLaurent Billot, Jeffrey Lipman, Stephen J Brett, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU studyJason A Roberts, Fekade Sime, Jeffrey Lipman, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2015
Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC projectMercedes Delgado-Valverde, Eva Torres, Adoración Valiente-Mendez, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Corrigendum to "Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis" [Crit Care Resusc 23(3) (2021) 273-284]Laurent Billot, Jeffrey Lipman, Stephen J Brett, et al.
Intensive Care Medicine|February 3, 2025
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units-the SAFE-ICU studyJason A Roberts, Fekade B Sime, Jeffrey Lipman, et al.
The Journal of Antimicrobial Chemotherapy|January 21, 2014
An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care unitsGloria Wong, Alexander Brinkman, Russell J Benefield, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Protocol for an international, multicentre, prospective, observational study of nosocomial pneumonia in intensive care units: the PneumoINSPIRE studyDespoina Koulenti, Apostolos Armaganidis, Kostoula Arvaniti, et al.
Intensive Care Medicine|June 11, 2020
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA studyLiesbet De Bus, Pieter Depuydt, Johan Steen, et al.
Wellcome Open Research|February 16, 2026
An oropharyngeal gonorrhoea controlled human infection model: a provisional protocol using a novel <i>Neisseria gonorrhoeae</i> challenge strainEloise Williams, Georgina L Pollock, David J Price, et al.
Clinical Pharmacokinetics|December 25, 2024
A Pooled Pharmacokinetic Analysis for Piperacillin/Tazobactam Across Different Patient Populations: From Premature Infants to the ElderlyDaming Kong, Jason A Roberts, Jeffrey Lipman, et al.
Pageof 61